Literature DB >> 21897187

Does bone morphogenetic protein increase the incidence of perioperative complications in spinal fusion? A comparison of 55,862 cases of spinal fusion with and without bone morphogenetic protein.

Brian J Williams1, Justin S Smith, Kai-Ming G Fu, D Kojo Hamilton, David W Polly, Christopher P Ames, Sigurd H Berven, Joseph H Perra, Dennis R Knapp, Richard E McCarthy, Christopher I Shaffrey.   

Abstract

STUDY
DESIGN: Retrospective review of a multi-institutional, multisurgeon database.
OBJECTIVE: Assess for associations between bone morphogenetic protein (BMP) use and rate of complications in spinal fusion. SUMMARY OF BACKGROUND DATA: BMP is commonly used in spinal surgery to augment fusion; however, there is limited evidence demonstrating its associated complications.
METHODS: We performed a retrospective analysis of all fusion cases submitted by members of the Scoliosis Research Society from 2004 to 2007. We stratified on the basis of the use of BMP and evaluated for complications and associated characteristics.
RESULTS: A total of 55,862 cases of spinal fusion were identified with BMP used in 21% (11,933) of the cases. Excluding anterior cervical fusions, there were no significant differences between fusions with and without BMP with regard to overall complications (8.4% vs. 8.5%; P = 0.5), wound infections (2.4% vs. 2.4%; P = 0.8), or epidural hematomas/seromas (0.2% vs. 0.2%; P = 0.3). Anterior cervical fusions with BMP were associated with more overall complications (5.8% vs. 2.4%; P < 0.001) and more wound infections (2.1% vs. 0.4%; P < 0.001) than fusions without BMP. On multivariate analysis for thoracolumbar and posterior cervical fusions, BMP use was not a significant predictor of complications (P = 0.334; odds ratio = 1.039; 95% confidence interval = 0.961-1.124; covariates were BMP use, patient age, revision vs. primary surgery). Multivariate analysis for anterior cervical spinal fusion demonstrated that BMP use remained a significant predictor of complications (P < 0.001, odds ratio = 1.6; 95% confidence interval = 1.516-1.721), after adjusting for the effects of patient age and whether the surgery was a revision procedure.
CONCLUSION: BMP use with anterior cervical fusion was associated with an increased incidence of complications. Use of BMP was not associated with more complications in thoracolumbar and posterior cervical fusions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21897187     DOI: 10.1097/BRS.0b013e318216d825

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  25 in total

1.  2011 AOA Symposium: Tissue Engineering and Tissue Regeneration: AOA critical issues.

Authors:  Scott A Rodeo; Scott D Boden; Martha M Murray; Thomas A Einhorn
Journal:  J Bone Joint Surg Am       Date:  2013-08-07       Impact factor: 5.284

2.  Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012.

Authors:  Brook I Martin; Jon D Lurie; Anna N A Tosteson; Richard A Deyo; Farrokh R Farrokhi; Sohail K Mirza
Journal:  Spine J       Date:  2014-12-15       Impact factor: 4.166

Review 3.  A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2.

Authors:  Aaron W James; Gregory LaChaud; Jia Shen; Greg Asatrian; Vi Nguyen; Xinli Zhang; Kang Ting; Chia Soo
Journal:  Tissue Eng Part B Rev       Date:  2016-04-19       Impact factor: 6.389

Review 4.  Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.

Authors:  Antonio Faundez; Clément Tournier; Matthieu Garcia; Stéphane Aunoble; Jean-Charles Le Huec
Journal:  Int Orthop       Date:  2016-03-10       Impact factor: 3.075

5.  Complications, revision fusions, readmissions, and utilization over a 1-year period after bone morphogenetic protein use during primary cervical spine fusions.

Authors:  Adam P Goode; William J Richardson; Robin M Schectman; Timothy S Carey
Journal:  Spine J       Date:  2013-12-07       Impact factor: 4.166

6.  How do coverage policies influence practice patterns, safety, and cost of initial lumbar fusion surgery? A population-based comparison of workers' compensation systems.

Authors:  Brook I Martin; Gary M Franklin; Richard A Deyo; Thomas M Wickizer; Jonathan D Lurie; Sohail K Mirza
Journal:  Spine J       Date:  2013-11-07       Impact factor: 4.166

7.  Reliability Of A Surgeon-Reported Morbidity And Mortality Database: A Comparison Of Short-Term Morbidity Between The Scoliosis Research Society And National Surgical Quality Improvement Program Databases.

Authors:  Christopher T Martin; Andrew J Pugely; Yubo Gao; Branko Skovrlj; Nathan J Lee; Samuel K Cho; Sergio Mendoza-Lattes
Journal:  Iowa Orthop J       Date:  2016

8.  Bone morphogenetic protein in complex cervical spine surgery: A safe biologic adjunct?

Authors:  Darren R Lebl
Journal:  World J Orthop       Date:  2013-04-18

9.  Rates of Mortality in Cervical Spine Surgical Procedures and Factors Associated With Its Occurrence Over a 10-Year Period: A Study of 342 477 Patients on the Nationwide Inpatient Sample.

Authors:  Gregory Wyatt Poorman; John Y Moon; Samantha R Horn; Cyrus Jalai; Peter L Zhou; Olivia Bono; Peter G Passias
Journal:  Int J Spine Surg       Date:  2018-08-03

10.  Controversy of physiological vs. pharmacological effects of BMP signaling: Constitutive activation of BMP type IA receptor-dependent signaling in osteoblast lineage enhances bone formation and resorption, not affecting net bone mass.

Authors:  Nobuhiro Kamiya; Phimon Atsawasuwan; Danese M Joiner; Erik I Waldorff; Steve Goldstein; Mitsuo Yamauchi; Yuji Mishina
Journal:  Bone       Date:  2020-06-27       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.